Ioannis Avgerinos

18PUBLICATIONS
19CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedPharmacogenomicsMajor global burdens of diseaseBehavioural epidemiologyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 04, 2026
In adults with T2D and ASCVD, tirzepatide was noninferior to dulaglutide for a composite CV outcome at a median 4 y.

|Jan 13, 2026
SGLT-2 Inhibitors and GLP-1 Receptor Agonists as Combination Therapy in Type 2 Diabetes.

Aris Liakos, Thomas Karagiannis, Ioannis Avgerinos

|Apr 13, 2024
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.

Thomas Karagiannis, Konstantinos Malandris, Ioannis Avgerinos

|Oct 23, 2023
Burden and Coping Strategies of Hypoglycemia in People with Diabetes.

Aris Liakos, Thomas Karagiannis, Ioannis Avgerinos

|Jul 12, 2023
Effects of sodium-glucose co-transporter-2 inhibitors by background cardiovascular medications: A systematic review and meta-analysis.

Ioannis Avgerinos, Thomas Karagiannis, David R Matthews

|Oct 19, 2022
Racial, ethnic and sex disparities among participants in cardiovascular outcomes trials in type 2 diabetes: A systematic review and descriptive analysis.

Ioannis Avgerinos, Thomas Karagiannis, Aris Liakos

Pageof 3

Frequent Collaborators

18 joint publications

Eleni Bekiari

17 joint publications

Thomas Karagiannis

15 joint publications

Aris Liakos

14 joint publications

Apostolos Tsapas